Analyst Price Target is $33.40
▲ +48.64% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for LifeStance Health Group in the last 3 months. The average price target is $33.40, with a high forecast of $36.00 and a low forecast of $25.00. The average price target represents a 48.64% upside from the last price of $22.47.
Current Consensus is
The current consensus among 6 investment analysts is to buy stock in LifeStance Health Group.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.